Caladrius Biosciences Inc. (NASDAQ: CLBS) is -15.54% lower on its value in year-to-date trading and has touched a low of $1.05 and a high of $3.64 in the current 52-week trading range. The CLBS stock was last observed hovering at around $2.12 in the recent trading session, with the current loss setting it -0.09%.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
At last check, trading at $2.03, the stock is 10.38% and 6.53% above its SMA20 and SMA50 respectively. However, with a current trading volume of 0.54 million and changing -4.48% at the moment leaves the stock -12.46% off its SMA200. CLBS registered -20.90% loss for a year compared to 6-month loss of -24.59%. The firm has a 50-day simple moving average (SMA 50) of $1.8668 and a 200-day simple moving average (SMA200) of $2.2571.
The stock witnessed a 7.61% gain in the last 1 month and extending the period to 3 months gives it a 12.77%, and is 19.10% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.07% over the week and 7.29% over the month.
Distance from 52-week low is 92.86% and -44.37% from its 52-week high.
Caladrius Biosciences Inc. (CLBS) Analyst Forecasts
Caladrius Biosciences Inc. quarterly earnings per share for the current quarter are estimated at -$0.39.The EPS is expected to shrink by -12.40% this year.
Caladrius Biosciences Inc. (CLBS) Top Institutional Holders
33 institutions hold shares in Caladrius Biosciences Inc. (CLBS), with 1.4M shares held by insiders accounting for 10.89% while institutional investors hold 23.38% of the company’s shares. The shares outstanding are 10.62M, and float is at 10.19M with Short Float at 1.56%. Institutions hold 20.84% of the Float.
Caladrius Biosciences Inc. (CLBS) Insider Activity
A total of 14 insider transactions have happened at Caladrius Biosciences Inc. (CLBS) in the last six months, with sales accounting for 6 and purchases happening 8 times.
Caladrius Biosciences Inc. (CLBS): Who are the competitors?
The company’s main competitors (and peers) include Vericel Corporation (VCEL) that is trading -22.60% down over the past 12 months. Short interest in the company’s stock has risen 58.48% from the last report on May 14, 2020 to stand at a total of 66030.0 short shares sold with a short interest ratio of 0.19.